Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma
โ Scribed by Dr. Bruce L. Webber; Herman Heise; James P. Neifeld; Jose Costa
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 463 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Tamoxifen commonly is used as adjuvant therapy for all stages of breast carcinoma. however, several studies have suggested an association between the use of tamoxifen in breast carcinoma patients and the subsequent development of endometrial carcinoma. the objective of this study was
Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
A number of epidemiologic studies have reported a reduced risk of breast carcinoma among women who have lactated but others have not. The current study presents data regarding lactation and breast carcinoma risk from a hospital-based case-control study of black and colored South African women. ##
## Background: Breast carcinoma and differentiated thyroid carcinoma(the most common endocrine malignancy) occur predominantly in women. an association between the two tumors has been suggested by some investigators, but the potential impact of treatment of one of these diseases on the development